Jeffrey C Webster

Title: The Innovations of Jeffrey C. Webster

Introduction

Jeffrey C. Webster is a notable inventor based in Jamestown, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of RAGE fusion proteins. With a total of 5 patents to his name, Webster's work has the potential to impact therapeutic approaches for various pathologies.

Latest Patents

Webster's latest patents include innovative methods involving RAGE fusion proteins. One patent discloses RAGE fusion proteins that comprise RAGE polypeptide sequences linked to a second, non-RAGE polypeptide. These fusion proteins utilize a RAGE polypeptide domain that includes a RAGE ligand binding site and an interdomain linker directly linked to an immunoglobulin C2 domain. This design allows for specific, high-affinity binding to RAGE ligands, which can be utilized therapeutically for RAGE-mediated pathologies. Another patent focuses on nucleic acid molecules encoding RAGE fusion proteins, emphasizing their formulations and therapeutic applications.

Career Highlights

Webster is currently associated with Transtech Pharma, Inc., where he continues to advance his research and development efforts. His work at Transtech Pharma has positioned him as a key player in the biotechnology sector, particularly in the realm of therapeutic innovations.

Collaborations

Throughout his career, Webster has collaborated with notable colleagues, including Adnan M. M. Mjalli and Robert Rothlein. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Jeffrey C. Webster's contributions to the field of biotechnology through his patents and work at Transtech Pharma, Inc. highlight his role as an influential inventor. His research on RAGE fusion proteins holds promise for future therapeutic advancements.